Bata, Bashar M <br/><br/>
Combined intraocular and systemic rituximab for ocular lymphoproliferative disorder with extranodal marginal zone lymphoma-type morphology after heart transplant.  [electronic resource] 

 -  Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus  04 2018 
 - 159-161 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-3933 
<br/><br/><label>Standard No.: </label>10.1016/j.jaapos.2017.10.016  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Immunological--therapeutic use<br/>Child<br/>Heart Transplantation<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Injections, Intraocular<br/>Iris Neoplasms--drug therapy<br/>Lymphoma, B-Cell, Marginal Zone--drug therapy<br/>Lymphoproliferative Disorders--drug therapy<br/>Male<br/>Postoperative Complications--drug therapy<br/>Rituximab--therapeutic use